The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: CCAAT/enhancer-binding protein-alpha (CEBPA) is crucial for normal granulopoiesis and is frequently disrupted in acute myeloid leukaemia (AML). Increasing evidence suggests that CEBPA exerts its effects, in parts, by regulating specific microRNAs (miRNAs), as previously shown for miR-223. The aim of this study was to investigate the genome-wide pattern of miRNAs regulated by CEBPA in myeloid cells. METHODS: In Kasumi-1 cells, conditionally expressing CEBPA, we assessed the expression of 470 human miRNAs by microarray analysis. We further investigated the microarray results by qRT-PCR, luciferase reporter assays, and chromatin immunoprecipitation assays. RESULTS: In all, 18 miRNAs were more than two-fold suppressed or induced after CEBPA restoration. Among these 18 miRNAs, we focused on CEBPA-mediated regulation of the tumour-suppressive miR-29b. We observed that miR-29b is suppressed in AML patients with impaired CEBPA function or loss of chromosome 7q. We found that CEBPA selectively regulates miR-29b expression on its miR-29a/b1 locus on chromosome 7q32.3, whereas miR-29b2/c on chromosome 1q32.2 is not affected. CONCLUSION: This study reports the activation of the tumour-suppressive miR-29b by the haematopoietic key transcription factor CEBPA. Our data provide a rationale for miR-29b suppression in AML patients with loss of chromosome 7q or CEBPA deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223
Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O., Brummelkamp, T. R., Fleming, M. D., & Camargo, F. D. (2008) · Nature · doi:10.1038/nature06607 · Cited by 1,208
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 1×
“It has been shown to be crucial for myeloid differentiation towards mature granulocytes (Zhang et al, 1997; Radomska et al, 1998).”
BackgroundPabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901 · cited 20×
“We used leukaemic Kasumi-1 cells lacking detectable amounts of endogenous CEBPA, however, containing an inducible CEBPA-ER fusion construct (Pabst et al, 2001a).”
BackgroundMethodSelf-citationPeltier, H. J., & Latham, G. J. (2008) · RNA · doi:10.1261/rna.939908 · Cited by 820 · cited 1×
“Expression values were normalised to the geometric mean (Peltier and Latham, 2008) of miR-93 and miR-191 expression (nos.”
MethodDisruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612 · cited 2×
“Deregulation of either haematopoietic transcription factors or miRNAs is a common event in the molecular pathogenesis of human leukaemias (Tenen, 2003; Kluiver et al, 2006; Rosenbauer and Tenen, 2007; Fabbri et al, 2008).”
BackgroundTranscription factors in myeloid development: balancing differentiation with transformation
Rosenbauer, F., & Tenen, D. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2024 · Cited by 606 · cited 3×
“Deregulation of either haematopoietic transcription factors or miRNAs is a common event in the molecular pathogenesis of human leukaemias (Tenen, 2003; Kluiver et al, 2006; Rosenbauer and Tenen, 2007; Fabbri et al, 2008).”
BackgroundRadomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., & Tenen, D. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4301 · Cited by 466 · cited 3×
“It has been shown to be crucial for myeloid differentiation towards mature granulocytes (Zhang et al, 1997; Radomska et al, 1998).”
BackgroundAML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463 · cited 22×
“We used leukaemic Kasumi-1 cells lacking detectable amounts of endogenous CEBPA, however, containing an inducible CEBPA-ER fusion construct (Pabst et al, 2001a).”
BackgroundMethodInfluentialSelf-citationFukao, T., Fukuda, Y., Kiga, K., Sharif, J., Hino, K., Enomoto, Y., Kawamura, A., Nakamura, K., Takeuchi, T., & Tanabe, M. (2007) · Cell · doi:10.1016/j.cell.2007.02.048 · Cited by 323
Cited by
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Kriegel, A. J., Liu, Y., Fang, Y., Ding, X., & Liang, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00141.2011 · Cited by 533
“Other studies have confirmed additional transcriptional factor binding sites including a Gli binding site at 424 and three NF- B binding sites at 561, 110, and 134 in the human miR-29b-1/a promoter (61); a Smad3 binding site in a highly conserved region 22 kb upstream of miR-29b-2 (72); at least one Yin-Yang-1 (YY1) b…”
BackgroundmiRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
Jones, K. B., Salah, Z., Del Mare, S., Galasso, M., Gaudio, E., Nuovo, G. J., Lovat, F., LeBlanc, K., Palatini, J., Randall, R. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2663 · Cited by 363
Tsukada, J., Yoshida, Y., Kominato, Y., & Auron, P. E. (2011) · Cytokine · doi:10.1016/j.cyto.2010.12.019 · Cited by 317
The prognostic and functional role of microRNAs in acute myeloid leukemia
Marcucci, G., Mrózek, K., Radmacher, M. D., Garzon, R., & Bloomfield, C. D. (2011) · Blood · doi:10.1182/blood-2010-09-191312 · Cited by 270
Neaga, A., Bagacean, C., Tempescul, A., Jimbu, L., Mesaros, O., Blag, C., Tomuleasa, C., Bocsan, C., Gaman, M., & Zdrenghea, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582915 · Cited by 30
“C/EBPa is an activator of miR-29a/b (75).”
Background
Metadata
- Authors
- Eyholzer, M., Schmid, S., Wilkens, L., Mueller, B. U., & Pabst, T.
- Venue
- British Journal of Cancer
- Published
- 2010-07
- Volume
- 103
- Issue
- 2
- Pages
- 275-284
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2115714464
- Cited by
- 115
- References
- 9
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.